Wake Forest School of Medicine Licenses Two Inventions to Foenestra Corporation
December 03, 2019
December 03, 2019
WINSTON-SALEM, North Carolina, Dec. 3 -- The Wake Forest Baptist Medical Center issued the following news release:
Two patent families and related technology for DNA detection and labeling developed by researchers at Wake Forest School of Medicine have been licensed to Foenestra Corporation, a private company that aims to enable more efficient identification and analysis of epigenetic modifications to accelerate research and diagnoses of diseases and conditions that are linked to th . . .
Two patent families and related technology for DNA detection and labeling developed by researchers at Wake Forest School of Medicine have been licensed to Foenestra Corporation, a private company that aims to enable more efficient identification and analysis of epigenetic modifications to accelerate research and diagnoses of diseases and conditions that are linked to th . . .